D
David M. Livermore
Researcher at University of East Anglia
Publications - 449
Citations - 49353
David M. Livermore is an academic researcher from University of East Anglia. The author has contributed to research in topics: Imipenem & Klebsiella pneumoniae. The author has an hindex of 109, co-authored 440 publications receiving 45157 citations. Previous affiliations of David M. Livermore include Cardiff University & Health Protection Agency.
Papers
More filters
Journal ArticleDOI
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Karthikeyan Kumarasamy,Mark Toleman,Timothy R. Walsh,Jay Bagaria,Fafhana Butt,Ravikumar Balakrishnan,Uma Chaudhary,Michel Doumith,Christian G. Giske,Seema Irfan,Padma Krishnan,Anil Kumar,Sunil Maharjan,Shazad Mushtaq,Tabassum Noorie,David L. Paterson,A. Pearson,Claire Perry,Rachel Pike,Bhargavi Rao,Ujjwayini Ray,Jayanta B. Sarma,Madhu Sharma,Elizabeth Sheridan,M A Thirunarayan,Jane F. Turton,Supriya Upadhyay,Marina Warner,William Welfare,David M. Livermore,Neil Woodford +30 more
TL;DR: The prevalence of NDM-1, in multidrug-resistant Enterobacteriaceae in India, Pakistan, and the UK is investigated, and co-ordinated international surveillance is needed.
Journal ArticleDOI
beta-Lactamases in laboratory and clinical resistance.
TL;DR: The ability of the prevalent beta-Lactamases to cause resistance to widely used beta-lactams, whether resistance is accurately reflected in routine tests, and the extent to which the antibiogram for an organism can be used to predict the type of beta- lactamase that it produces are considered.
Journal ArticleDOI
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
TL;DR: Pseudomonas aeruginosa carries multiresistance plasmids less often than does Klebsiella pneumoniae, develops mutational resistance to cephalosporins less readily than Enterobacter species, and has less inherent resistance than Stenotrophomonas maltophilia.
Journal ArticleDOI
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price,L. Silvia Munoz-Price,Laurent Poirel,Robert A. Bonomo,Robert A. Bonomo,Mitchell J. Schwaber,George L. Daikos,Martin Cormican,Giuseppe Cornaglia,Javier Garau,Marek Gniadkowski,Mary K. Hayden,Karthikeyan Kumarasamy,David M. Livermore,David M. Livermore,Juan J. Maya,Patrice Nordmann,Jean B. Patel,David L. Paterson,Johann D. D. Pitout,Maria Virginia Villegas,Hui Wang,Neil Woodford,John P. Quinn +23 more
TL;DR: The epidemiology of Klebsiella pneumoniae carbapenemases across continents is summarized, issues around detection, present antibiotic options and those in development, treatment outcome and mortality, and infection control are discussed.
Journal ArticleDOI
Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
TL;DR: The presence of NDM-1 β-lactamase-producing bacteria in environmental samples in New Delhi has important implications for people living in the city who are reliant on public water and sanitation facilities.